Company Name: Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of treatments for central nervous system disorders. The company’s developmental pipeline includes product candidates for conditions that include:
- Major depressive disorder
- Parkinson’s disease
Ticker Symbol: NERV (NASDAQ)
Company Website: http://minervaneurosciences.com
Headquarters: Waltham, MA